Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Sales Advisor – Ibiza Salary: Up to €38,000 basic + Exceptional Commission + €9 Daily Restaurant Ticket Contract: Fixed-Term Contract until the end of October We are partnering with one of the worlds most prestigious luxury